- When Less is More: De-escalation of Locoregional Treatment for Early-stage Breast Cancer
- Sequencing after Frontline CDK4/6: Do you continue with a CDK4/6i or switch therapy?
- Reshaping Advanced or Metastatic Breast Cancer: Antibody-Drug Conjugates (ADC)
- Optimal Treatment Selection of PARP Inhibitors in Ovarian Cancer
- Antibody-Drug Conjugates in Ovarian and Cervical Cancers
- Frontline Treatment Advances in Endometrial Cancer
- Live Q&A
OncLive® State of the Science Summit™: Women's Health
Courtyard by Marriott Philadelphia Downtown
1421 Arch Street
Philadelphia, Pennsylvania 19102
June 16, 2025
6:00 PM-9:00 PM ET
In-Person Only
IN PARTNERSHIP WITH
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Venue Location
Courtyard by Marriott Philadelphia Downtown1421 Arch Street, Philadelphia, Pennsylvania 19102, USA
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
2 Commerce Drive
Cranbury, NJ 08512